Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,856
datasets available to search
ShareScore release 0.9.0
Dataset results
5,856 results for “B cells”
Dual Target CAR-T Cells in B-cell Acute Lymphoblastic Leukemia
ClinicalTrials.gov study NCT04723901. IPD Sharing: NO. Countries: 1. Publications: 0.
The Safety and Efficacy of CART-19 Cells in Relapse and Refractory Patients With CD19+ B-cell Lymphoma
ClinicalTrials.gov study NCT03101709. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Epcoritamab With Dose Adjusted Etoposide, Cyclophosphamide, Vincristine, Doxorubicin, Prednisone and Rituximab (EPOCH-R) for the Treatment of Aggressive B-Cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT07097363. IPD Sharing: NO. Countries: 1. Publications: 0.
CD19 CAR-T Cells for Patients With Relapse and Refractory CD19+ B-ALL.
ClinicalTrials.gov study NCT03263208. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase I Study of Alisertib + R-EPOCH for Treatment of Myc-Positive Aggressive B-cell Lymphomas
ClinicalTrials.gov study NCT02700022. IPD Sharing: NO. Countries: 1. Publications: 0.
Drug-Eluting Bead-Based Transarterial Chemoembolization (DEB-TACE) as a Local Salvage Therapy for Large Lesions in Relapsed and Refractory Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT07198230. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Yt90 Zevalin and Combination Chemotherapy (Z-CHOP)in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT00386321. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Blinatumomab for MRD in Pre-B ALL Patients Following Stem Cell Transplant
ClinicalTrials.gov study NCT04044560. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Golcadomide and Rituximab as Bridging Therapy for Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma Before CAR T-cell Therapy
ClinicalTrials.gov study NCT06834373. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy of PRG-2302 for Refractory or Relapsed B-cell Acute Lymphoblastic Leukemia Disease.
ClinicalTrials.gov study NCT06659653. IPD Sharing: NO. Countries: 1. Publications: 0.
Pirtobrutinib in Combination With Rituximab, Gemcitabine, Oxaliplatin With or Without Polatuzumab Vedotin in Covalent BTK Inhibitor-Pretreated Relapsed/Refractory Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT07122609. IPD Sharing: NO. Countries: 1. Publications: 0.
A Safety and Efficacy Study of CNTO 328 in Patients With B-Cell Non-Hodgkin's Lymphoma, Multiple Myeloma, or Castleman's Disease
ClinicalTrials.gov study NCT00412321. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab or Glofitamab in Combination With CC-220 and/or CC-99282 in Participants With B-Cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT05169515. IPD Sharing: NO. Countries: 5. Publications: 0.
LIBERTY: Liquid Biopsy to Diagnose and Monitor CNS Involvement in High-risk B Cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT06090162. IPD Sharing: Not stated. Countries: 1. Publications: 0.
LEF1 EXPRESSION IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS: A MARKER FOR DIAGNOSIS AND SURVIVAL PREDICTION
ClinicalTrials.gov study NCT07313982. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluation of the Redox Profiles of Healthy and Pathological B Cells in Patients With Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT03971565. IPD Sharing: NO. Countries: 1. Publications: 0.
The Effectiveness and Safety of Glofitamab in Real-World Clinical Practice Among Chinese Adult Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Prospective, Observational, Multice
ClinicalTrials.gov study NCT06656234. IPD Sharing: NO. Countries: 1. Publications: 0.
Clinical Study of Cord Blood-derived CAR-NK Cells Targeting CD19 in the Treatment of Refractory/Relapsed B-cell NHL
ClinicalTrials.gov study NCT05472558. IPD Sharing: NO. Countries: 1. Publications: 0.
Maintenance Therapy of Chidamide in Patients With HBV Positive Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT04661943. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase I Safety, PK and PD Study of KW-2478 in Patients With Multiple Myeloma, Chronic Lymphocytic Leukaemia or B-cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00457782. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.